risk stratification in acute lymphoblastic leukemia in the era of mrd and ngs: dr shweta bansal
Published Streamed 3 years ago • 739 plays • Length 1:06:06Download video MP4
Download video MP3
Similar videos
-
4:37
advances in risk-stratification in pediatric all
-
3:02
enhanced risk stratification in pediatric all
-
4:35
learn about measurable residual disease (mrd)
-
0:56
future perspectives in the treatment of acute lymphoblastic leukemia
-
15:02
the evolving landscape of all therapy and the impact of mrd
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
9:20
mrd to support treatment planning in a young, high-risk all patient
-
22:56
measurable residual disease (mrd) in aml and all
-
4:45
development of a risk stratifying prognostic index for all
-
3:40
awareness is a way to save your child from the cancer | dr. shweta bansal
-
2:04
mrd in pediatric all: clinical evidence, treatment decisions & outcomes
-
2:04
risk stratification and the importance of mrd (aml)
-
34:52
measurable residual disease in acute myeloid leukemia mrd in aml
-
1:24:07
appraise to raise presents: a tums webinar on measurable residual disease in acute leukemia.
-
6:50
case 2: molecular risk stratification in myeloma
-
47:18
diagnosis and risk assessment in multiple myeloma
-
1:05:11
measurable residualdisease testing in acutelymphoblastic leukemia: testing, sampling, and guidelines